integrin inhibitors (Trifermed)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameintegrin inhibitors (Trifermed)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsInflammationThrombosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrifermed SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrifermed SL
Active IndicationsN/A
Inactive IndicationsInflammationThrombosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A